|
Volumn 148, Issue 3, 2014, Pages 693-
|
BCRT response to Moller
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER EPIDEMIOLOGY;
CANCER GRADING;
CANCER PROGNOSIS;
CANCER RISK;
CANCER SCREENING;
CANCER SURVIVAL;
GENE MUTATION;
HETEROZYGOTE;
HUMAN;
LETTER;
LYMPH NODE METASTASIS;
MAMMOGRAPHY;
MASTECTOMY;
NORWAY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RISK REDUCTION;
TRIPLE NEGATIVE BREAST CANCER;
TUMOR SUPPRESSOR GENE;
UNITED KINGDOM;
CARCINOMA, DUCTAL, BREAST;
EARLY DIAGNOSIS;
FEMALE;
PROCEDURES;
CARCINOMA, DUCTAL, BREAST;
EARLY DETECTION OF CANCER;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MAMMOGRAPHY;
|
EID: 84912011647
PISSN: 01676806
EISSN: 15737217
Source Type: Journal
DOI: 10.1007/s10549-014-3200-7 Document Type: Letter |
Times cited : (1)
|
References (5)
|